DEC 17, 2013
Labcyte Commends Early Success of Collaborator, The Institute for Molecular Medicine Finland, for Personalized Leukemia Treatment Method
Just eight months after announcing a collaboration between Labcyte Inc. and the Institute for Molecular Medicine Finland (FIMM), the partnership has already led to a groundbreaking method for personalized treatment of patients with adult acute myeloid leukemia (AML).